Thyroid-Stimulating Hormone Testing and Outcomes in Total Laryngectomy Patients
Annals of Otology, Rhinology & Laryngology · 2025
DOI: 10.1177/00034894251320883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Otology, Rhinology & Laryngology, 2025. Verfasst von James D Warren und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Mississippi Medical Center, Jackson, MS, USA. Hauptthemen laut MEDLINE: Laryngectomy, Hypothyroidism, Thyrotropin, Thyroidectomy. Die Arbeit nennt 58 Literaturangaben.
Abstract (Originalsprache)
Objective
Assess timing and prevalence of thyroid-stimulating hormone (TSH) testing after total laryngectomy (TL). Identify prevalence of postoperative hypothyroidism and determine associations between thyroidectomy, postoperative hypothyroidism, and wound complications, including pharyngocutaneous fistula (PCF).
Methods
Retrospective chart review performed at 2 tertiary care centers of adult patients undergoing TL between 2013 and 2021. Demographic data, perioperative labs and post-operative outcomes were collected. Analysis was performed.
Results
Of 237 patients identified, thyroid removal was performed in 156 (65.8%), including 23 (9.7%) total thyroidectomies and 133 (56.1%) hemi-thyroidectomies. Of the 191 (80.6%) receiving postoperative TSH testing, 98 (41.4%) had TSH testing within 90 days, and 112 (58.6%) developed hypothyroidism. Mean postoperative TSH testing interval was 222.0 days (SSD 400.2), with variations associated with age ( P = .026), gender ( P = .009), PCF formation ( P < .001), history of radiation therapy (RT, P = .011), and preoperative levothyroxine use ( P = .031). Partial or total thyroid removal significantly increased the likelihood of high postoperative TSH (OR = 2.631, P = .002, 95% CI [1.410, 4.911]). PCF occurred in 62 (26.2%) patients, and there were no significant associations between pre/postoperative TSH or thyroid removal and PCF development or wound complications.
Conclusion
Thyroidectomy was associated with elevated postoperative TSH levels, adding support to prior literature for consideration of avoiding thyroid removal during TL when appropriate. The wide range of TSH testing intervals and prevalence of postoperative hypothyroidism in our cohort highlights the importance of monitoring thyroid function in TL patients during the perioperative period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
- Department of Otolaryngology - Head and Neck Surgery, University of Mississippi Medical Center, Jackson, MS, USA.
- University of Missouri School of Medicine, Jackson, MS, USA.
- Department of Otolaryngology - Head and Neck Surgery, University of Missouri, Jackson, MS, USA.
ORCID-Profile: James D Warren, Patrick Tassone
Zitieren
APA
Warren, J. D., Oglesby, K. R., Homan, C. R., Howe, E., Paul, O., Tassone, P., & Kane, A. C. (2025). Thyroid-Stimulating Hormone Testing and Outcomes in Total Laryngectomy Patients. Annals of Otology, Rhinology & Laryngology. https://doi.org/10.1177/00034894251320883
Vancouver
Warren JD, Oglesby KR, Homan CR, Howe E, Paul O, Tassone P, et al. Thyroid-Stimulating Hormone Testing and Outcomes in Total Laryngectomy Patients. Annals of Otology, Rhinology & Laryngology. 2025. doi:10.1177/00034894251320883
BibTeX
@article{Warren2025,
author = {Warren, James D and Oglesby, Kacie R and Homan, Carlton R and Howe, Edmund and Paul, Oishika and Tassone, Patrick and Kane, Anne C},
title = {Thyroid-Stimulating Hormone Testing and Outcomes in Total Laryngectomy Patients},
journal = {Annals of Otology, Rhinology & Laryngology},
year = {2025},
doi = {10.1177/00034894251320883}
}
EUVIMED